---
action_items:
- id: 1a77ac464906
  severity: science
  text: Report confidence intervals or standard deviations for the three repeated
    runs. Point estimates alone cannot validate the claimed ~30% F1 improvements as
    statistically significant.
- id: 49fc54592e55
  severity: science
  text: Add statistical significance tests (e.g., paired t-tests) for DRIFT vs. baselines
    and ablation comparisons to confirm gains are not due to random variance.
- id: 8c65d4f6fb8b
  severity: science
  text: Provide 95% confidence intervals for normalized error rates in the appendix
    (e.g., 60.5% for decision-making) to support claims about stage-specific risk.
artifact_hash: 35ded812a75ceef1f48d0fbc3a809a8b976c23d29d82ed40e43751cfcaadee3e
artifact_path: projects/PROJ-664-https-arxiv-org-abs-2606-02060/paper/metadata.json
backend: dartmouth
feedback: ''
github_authenticated: false
model_name: qwen.qwen3.5-122b
prompt_version: 1.1.0
reviewed_at: '2026-07-02T03:03:57.471753Z'
reviewer_kind: llm
reviewer_name: paper_reviewer_statistical_analysis
score: 0.0
verdict: minor_revision
---

The statistical reporting in the experimental section requires strengthening to support the strong claims of performance improvement. While the paper provides point estimates for Precision, Recall, F1, and First-Error Accuracy (FEA) across multiple models and baselines, it lacks measures of uncertainty. The statement that "Each setting is repeated three times" (Experiment Settings, line 4) implies that variance data exists, yet the results tables (Table 1) and figures (Figure 1, Figure 2) only display single-point values. In LLM evaluation, where stochasticity can lead to significant variance, reporting only the mean without standard deviation or confidence intervals makes it difficult to assess the reliability of the reported gains (e.g., the ~30% F1 improvement).

Specifically, the claim that DRIFT "outperforms... by up to 30 percentage points" needs statistical backing. A paired statistical test (such as a paired t-test or Wilcoxon signed-rank test) across the three runs for each model-benchmark pair should be conducted to determine if the improvements are statistically significant (p < 0.05). Similarly, the ablation study in Figure 2c and the appendix should include error bars or significance markers to validate that the incremental gains from specific modules are not due to chance.

Furthermore, in the mechanism analysis (Appendix, Stage-normalized error risk), the paper reports specific error rates (e.g., 60.5% for decision-making). These are proportions derived from a finite sample of spans. To rigorously support the conclusion that certain stages are "intrinsically more error-prone," the authors should report 95% confidence intervals for these proportions. Without these intervals, the distinction between stages with similar rates (e.g., 60.5% vs. 51.8%) may not be statistically meaningful. Adding these statistical rigor elements will significantly enhance the credibility of the empirical findings.
